Dr. Paul Yu is Director of the Cardiovascular Research Center (CVRC) at Massachusetts General Hospital, recipient of the Charles Addison Sanders and Elizabeth Ann Sanders Endowed Chair, Associate Professor of Medicine at Harvard Medical School, and Physician in Cardiovascular Medicine at Massachusetts General Hospital (MGH).

Dr. Paul Yu is Director of the Cardiovascular Research Center (CVRC) at Massachusetts General Hospital, recipient of the Charles Addison Sanders and Elizabeth Ann Sanders Endowed Chair, Associate Professor of Medicine at Harvard Medical School, and Physician in Cardiovascular Medicine at Massachusetts General Hospital (MGH).

Paul B. Yu. Director, Cardiovascular Research Center, MGH; Sanders Endowed Chair, Harvard Medical School. Verified email at partners.org. Vascular and Musculoskeletal Biology. Articles Cited by Public access Co-authors. Title. Sort. Sort by citations Sort by year Sort by title.

No Ratings Available - Why Not? Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.

Paul Yu (simplified Chinese: 余英华; traditional Chinese: 余英華) was a Chinese-American academic who was the President of State University of New York at Brockport (SUNY Brockport) between 1997–2004.

2023年11月28日 · Novel Imaging Approaches to Cardiac Manifestations of Systemic Inflammatory Diseases: JACC Scientific Statement. Angiogenesis Redux: An Overall Protective Role of VEGF/KDR Signaling in the Microvasculature in Pulmonary Arterial Hypertension. Authors: Authors: Zhong Y, Yu PB.

To broaden her knowledge of the role of TGF-β family members in pulmonary vascular remodeling and diseases, Dr. Zhong joined Dr. Paul Yu’s laboratory in 2021. She is interested in testing the efficacy of the recombinant traps of TGF-β family ligands in treating pulmonary arterial hypertension (PAH).

Paul K.L. Yu joined the UCSD faculty in 1983 and is a professor in the Electrical and Computer Engineering Department. He is one of five professors responsible for UCSD's Integrated Technologies Laboratory, which makes experimental electronic devices. Since January 2000, Yu has been an academic participant in the Calit2 Materials and Devices group.

Dr. Paul B. Yu is a cardiovascular medicine specialist at Brigham and Women’s Hospital and an associate professor of medicine at Harvard Medical School. He received his medical degree from Duke University School of Medicine.

R42HL132742 (YU, PAUL B) Aug 15, 2017 - Aug 31, 2020 NIH HLS- Cyclic CAR peptide: a targeted therapy for pulmonary hypertension